This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Its becoming more expensive and time-consuming to move a drug from the clinicaltrial stage to approval. Patient recruitment is the leading driver of costs in clinicaltrials, and 55% of trials that fail to complete cite low accrual rate as the reason for study termination.
Nate Lear Head, Advanced Analytics and ClinicalTrial Efficiency AstraZeneca Recent advances in AI are ushering in a new era for cancer care. AI is transforming screening, drug discovery and clinical decision support. These innovations promise earlier cancer detection using improved imaging and liquid biopsy techniques.
Samsung Biologics and GreenLight Biosciences have completed the initial commercial-scale engineering run for their messenger ribonucleic acid (mRNA) Covid-19 vaccine under their manufacturing collaboration. Following the demonstration at Samsung, the clinicaltrial of GreenLight’s Covid-19 booster vaccine is anticipated to commence this year.
BlueRock Therapeutics, a subsidiary of Bayer AG, is making waves in the treatment of Parkinsons disease by advancing its investigational cell therapy, bemdaneprocel, to a Phase III clinicaltrial. These stem cells are engineered to develop into dopamine-producing neurons, which are progressively lost in Parkinsons disease.
It’s even being used to review investigator invoices and automate financial reconciliations—a monthly headache every contract research organization, sponsor, and clinicaltrials operator will be more than happy to resign to machines. MGI puts the value of this contribution to clinical development at $15 billion to $25 b illion.
A special series of articles addressing pragmatic and virtual trials appears this week in the journal Contemporary ClinicalTrials and offers practical approaches to the many challenges clinicaltrials face. The special issue can be found on the Contemporary ClinicalTrials website.
There is no denying that trial complexity is continuing to increase. Several factors in recent years have contributed to this rise including more complex trial designs, the rapid adoption of decentralisation stemming from the pandemic, and larger global trials. Demand planning drives trial efficiency.
The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinicaltrial space. Hybrid or decentralised clinicaltrials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use. Source: Izmailova et al, 2017.
An experimental vaccine that aims to slow down or prevent the progression of Alzheimer’s disease has been trialed in mice with promising early results. Mice engineered with genes that put them at greater risk of an Alzheimer’s-like disease had fewer amyloid plaques following the vaccine.
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinicaltrials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinicaltrial design that have historically led to trial failure?
Being co-developed and co-marketed by Daiichi Sankyo along with AstraZeneca , Enhertu is a specifically engineered HER2-directed antibody-drug conjugate (ADC). Enhertu’s safety profile was consistent with the previous clinicaltrials.
The protein-based vaccine is engineered from the genetic sequence of the SARS-CoV-2 virus’ initial strain. The totality of preclinical, manufacturing and clinicaltrial findings that were submitted for analysis formed the basis for the EUA. The vaccine showed an encouraging safety and tolerability profile in both trials.
ARTHEx Biotech will use the funds to advance an antimiR oligonucleotide, ATX-01, to a Phase I/IIa clinicaltrial in the second half of 2023. New investors Sound Bioventures, Hadean Ventures and the European Innovation Council (EIC) fund have also participated.
Clinicaltrials are the engine for pharmaceutical innovation, but their means of capturing and communicating data are stuck in the past. According to Peleg, one of the biggest inefficiencies is in the process of collecting and streaming data from participants at trial sites to the trial organisers.
In March last year, CanSinoBIO obtained approval for the clinicaltrial application to analyse Convidecia Air. Administered as a single dose, the genetically engineered vaccine has the replication-defective adenovirus type 5 vector that expresses the spike S protein of the SARS-CoV-2 virus.
(Engin Akyurt/Pixabay) If you’re in a lot of pain, being told to take deep breaths and accept the sensations in your body might not feel particularly comforting.
Engineers at the University of California San Diego (UCSD) have used cutting-edge technology to analyze the postmortem brains of 14 donors aged over 59, some of whom died with Alzheimer’s disease and some of whom […]
The lack of diversity in clinicaltrials unfairly skews American medicine and costs billions of dollars a year in early deaths and poor health. The scope of the problem was laid out in a new report that Congress requested from the National Academies of Sciences, Engineering, and Medicine, which we as committee members helped write.
The latest approval was based on the findings from the Phase II DESTINY-Lung02 clinicaltrial, which assessed the safety and efficacy of two doses of Enhertu in HER2 mutant metastatic NSCLC patients. . In the trial, 1.9% According to the interim efficacy data from a pre-specified patient cohort, a 5.4
Dudley Tabakin, CEO of VivoSense, describes how this financing is set to accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments. How can this data be incorporated into clinicaltrials?”. How can this data be incorporated into clinicaltrials?”. Tabakin agrees. “In
Ginkgo Bioworks has strengthened its end-to-end R&D capabilities in gene therapy with the purchase of adeno-associated virus (AAV) capsid discovery and engineering assets from StrideBio, for an undisclosed sum. AAV is used in hundreds of active clinicaltrials, and is described as the preferred viral vector for gene therapy.
Mechanical engineer and inventor Zach Lerner, assistant professor in Northern Arizona University’s Department of Mechanical Engineering, has been awarded $2.1 Credit: Northern Arizona University Mechanical engineer and inventor Zach Lerner, assistant professor in Northern Arizona University’s Department […].
New research from ETH Zürich in Switzerland could see future wearable devices (with perhaps a few implants and a touch of genetic engineering) boost our health directly. Fitness trackers help you stay healthy by keeping count of your steps and monitoring your heart rate, driving you on to hit those cardio goals.
The integration of a Clinical Metadata Repository (CMDR) and a Clinical Data Repository (CDR) presents the opportunity to maximize automation across the end-to-end clinicaltrial lifecycle. This functionality offered the perfect synergy with our ryze Clinical Metadata Repository (CMDR) and automation platform.
Briumvi is an anti-CD20 monoclonal antibody indicated for RMS adult patients with active disease which is defined by clinical or imaging features. It has been engineered to remove certain sugar molecules generally expressed on the antibody. The therapy targets a unique epitope on CD20-expressing B-cells.
Rishi Kundi, a clinical investigator at the University of Maryland Medical System, believes Symvess holds the potential to transform vascular trauma care by overcoming longstanding challenges like infection control and graft failure that have plagued traditional repair methods.
Joe Dituri, a former US navy diver and expert in biomedical engineering has been living in a 55 square meter (592 square feet) space 30 feet below the […] As nightmares go, being trapped in a small box deep underwater is probably high on many people’s lists. But one US professor is doing this on purpose.
The robust expertise of IASO in monitoring possibly best-in-class CARs leveraging its fully-human antibody discovery platform (IMARS), quickly conducting clinicaltrials and its in-house GMP facility for producing plasmid, virus vector and CAR-T cells intends to make its new therapies available to larger population across the world.
Patient-centricity isn’t a catchphrase in clinicaltrials—it’s a guiding principle for improving patient experiences. One of the most critical aspects of this is how patients are compensated for their participation in trials. Meghan Harrington VP, ClinicalTrial Financial Management Medidata Alicia C.
Engine is ready to drive its lead program into clinicaltrials by 2023 while Giiant’s preclinical program will target moderate-to-severe ulcerative colitis.
Eneboparatide (AZP-3601), an investigational parathyroid hormone 1 receptor (PTH1R) agonist, met its primary endpoint in the CALYPSO Phase III trial, offering new data for adults with chronic hypoparathyroidism. Participants were randomized in a 2:1 ratio to receive eneboparatide or a placebo.
Lupus is a disease long-plagued by failed clinicaltrials. Together, they created what lupus advocates hope will be an engine for innovation: the Lupus Accelerating Breakthroughs Consortium, or Lupus ABC. A key partnership is looking to change that. Read the rest…
Recombinant DNA technologies and genetically modified biological agents are being adapted for a wide scope of therapeutic applications, and their use is becoming increasingly common in clinicaltrials. How can I protect myself from exposure? What should I do if I’m exposed?
The finding was made as part of a study published in the journal Nature Biomedical Engineering. Kelley added: “Engineering-based tools allow you to do things that open up new areas of biology. CTRL Therapeutics will file an application with the US Food and Drug Administration (FDA) to advance the new platform into clinicaltrials.
CIGB-128 is under clinical development by Center for Genetic Engineering and Biotechnology and currently in Phase I for Brain Tumor. Attributes of the drug, company and its clinicaltrials play a fundamental role in drug-specific PTSR and likelihood of approval.
CIGB-128 is under clinical development by Center for Genetic Engineering and Biotechnology and currently in Phase I for Brain Tumor. Attributes of the drug, company and its clinicaltrials play a fundamental role in drug-specific PTSR and likelihood of approval.
These two molecules are presently being analysed by the research and development (R&D) team of Sanofi, with one currently being evaluated in clinicaltrials. Initially, the companies signed a research collaboration and licensing agreement in 2016 to develop and assess up to two bispecific NK cell engagers.
The shot engineered by Bharat Biotech was, in part, an important effort to create a home-grown product that could bolster the fortunes of the Indian pharmaceutical industry. Read the rest…
The genetic engineering startup, recently honored by BioSpace readers for its work environment, is downsizing as it seeks to launch its first clinicaltrials.
At Antidote, our mission is to connect patients with clinicaltrials using a data-driven, technological approach — and one of the ways we do that is through our clinicaltrial search engine, Antidote Match ™.
The FDA wants pharmaceutical and medical device manufacturers to enroll diverse patients in clinicaltrials. One way to achieve the diversity goal is to engage with physicians in the community and provide them with the resources and support to conduct clinicaltrials. Chris holds a B.S. Chris holds a B.S.
To learn more about clinicaltrials in diabetes, I invited Dr. Stayce Beck, Global Vice President of Clinical Affairs at Dexcom Inc. in Chemical Engineering from the University of Texas at Austin. on the podcast. in Biomedical Science from the University of California San Diego, and her B.S.
Today, Antidote is excited to announce our collaboration with Beyond Type 1 and JDRF to release the first-ever Spanish-language clinicaltrial search engine for type 1 diabetes (T1D).
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content